United States Antihypertensive Drugs Market Report 2016

November 2016 | 120 pages | ID: U0134FB22D7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antihypertensive Drugs

Revenue, means the sales value of Antihypertensive Drugs

This report studies sales (consumption) of Antihypertensive Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis AG
• Pfizer
• Sanofi S.A
• Johnson & Johnson
• Daiichi Sankyo
• Merck & Co.
• Ranbaxy Laboratories
• Lupin
• AstraZeneca
• Dr. Reddy's Laboratories

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Angiotensin Converting Enzyme Inhibitors (ACE)
• Diuretics
• Beta Blockers
• Calcium Channel Blockers
• Vasodilators
• Alpha blockers
• Renin inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Antihypertensive Drugs in each application, can be divided into

• Diagnostic centers
• Hospitals
• Home health care

Contents

United States Antihypertensive Drugs Market Report 2016

1 ANTIHYPERTENSIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Antihypertensive Drugs
1.2 Classification of Antihypertensive Drugs
  1.2.1 Angiotensin Converting Enzyme Inhibitors (ACE)
  1.2.2 Diuretics
  1.2.3 Beta Blockers
  1.2.4 Calcium Channel Blockers
  1.2.5 Vasodilators
  1.2.6 Alpha blockers
  1.2.7 Renin inhibitors
1.3 Application of Antihypertensive Drugs
  1.3.1 Diagnostic centers
  1.3.2 Hospitals
  1.3.3 Home health care
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antihypertensive Drugs (2011-2021)
  1.4.1 United States Antihypertensive Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Antihypertensive Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIHYPERTENSIVE DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Antihypertensive Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antihypertensive Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antihypertensive Drugs Average Price by Manufactures (2015 and 2016)
2.4 Antihypertensive Drugs Market Competitive Situation and Trends
  2.4.1 Antihypertensive Drugs Market Concentration Rate
  2.4.2 Antihypertensive Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIHYPERTENSIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Antihypertensive Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Antihypertensive Drugs Price by Type (2011-2016)
3.4 United States Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTIHYPERTENSIVE DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Antihypertensive Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTIHYPERTENSIVE DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis AG
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Antihypertensive Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer
  5.2.2 Antihypertensive Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi S.A
  5.3.2 Antihypertensive Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Johnson & Johnson
  5.4.2 Antihypertensive Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Daiichi Sankyo
  5.5.2 Antihypertensive Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Merck & Co.
  5.6.2 Antihypertensive Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Ranbaxy Laboratories
  5.7.2 Antihypertensive Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lupin
  5.8.2 Antihypertensive Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 AstraZeneca
  5.9.2 Antihypertensive Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Dr. Reddy's Laboratories
  5.10.2 Antihypertensive Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 ANTIHYPERTENSIVE DRUGS MANUFACTURING COST ANALYSIS

6.1 Antihypertensive Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Antihypertensive Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Antihypertensive Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTIHYPERTENSIVE DRUGS MARKET FORECAST (2016-2021)

10.1 United States Antihypertensive Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Antihypertensive Drugs Sales Forecast by Type (2016-2021)
10.3 United States Antihypertensive Drugs Sales Forecast by Application (2016-2021)
10.4 Antihypertensive Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antihypertensive Drugs
Table Classification of Antihypertensive Drugs
Figure United States Sales Market Share of Antihypertensive Drugs by Type in 2015
Figure Angiotensin Converting Enzyme Inhibitors (ACE) Picture
Figure Diuretics Picture
Figure Beta Blockers Picture
Figure Calcium Channel Blockers Picture
Figure Vasodilators Picture
Figure Alpha blockers Picture
Figure Renin inhibitors Picture
Table Application of Antihypertensive Drugs
Figure United States Sales Market Share of Antihypertensive Drugs by Application in 2015
Figure Diagnostic centers Examples
Figure Hospitals Examples
Figure Home health care Examples
Figure United States Antihypertensive Drugs Sales and Growth Rate (2011-2021)
Figure United States Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Table United States Antihypertensive Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Antihypertensive Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antihypertensive Drugs Sales Share by Manufacturers
Figure 2016 Antihypertensive Drugs Sales Share by Manufacturers
Table United States Antihypertensive Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Antihypertensive Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antihypertensive Drugs Revenue Share by Manufacturers
Table 2016 United States Antihypertensive Drugs Revenue Share by Manufacturers
Table United States Market Antihypertensive Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antihypertensive Drugs Average Price of Key Manufacturers in 2015
Figure Antihypertensive Drugs Market Share of Top 3 Manufacturers
Figure Antihypertensive Drugs Market Share of Top 5 Manufacturers
Table United States Antihypertensive Drugs Sales by Type (2011-2016)
Table United States Antihypertensive Drugs Sales Share by Type (2011-2016)
Figure United States Antihypertensive Drugs Sales Market Share by Type in 2015
Table United States Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
Table United States Antihypertensive Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antihypertensive Drugs by Type (2011-2016)
Table United States Antihypertensive Drugs Price by Type (2011-2016)
Figure United States Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)
Table United States Antihypertensive Drugs Sales by Application (2011-2016)
Table United States Antihypertensive Drugs Sales Market Share by Application (2011-2016)
Figure United States Antihypertensive Drugs Sales Market Share by Application in 2015
Table United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Antihypertensive Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antihypertensive Drugs Sales Market Share (2011-2016)
Table Sanofi S.A Basic Information List
Table Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A Antihypertensive Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Antihypertensive Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Antihypertensive Drugs Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Antihypertensive Drugs Sales Market Share (2011-2016)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ranbaxy Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)
Table Lupin Basic Information List
Table Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lupin Antihypertensive Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antihypertensive Drugs Sales Market Share (2011-2016)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive Drugs
Figure Manufacturing Process Analysis of Antihypertensive Drugs
Figure Antihypertensive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
Table Major Buyers of Antihypertensive Drugs
Table Distributors/Traders List
Figure United States Antihypertensive Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Antihypertensive Drugs Production Forecast by Type (2016-2021)
Table United States Antihypertensive Drugs Consumption Forecast by Application (2016-2021)